
Wildfire smoke is reversing years of air quality gains, and fire season now stretches across the year.
Photo Credit: Arnav Kainthola
Scientific Frontline: Extended "At a Glance" Summary: Wildfire Smoke and Airway Defenses
The Core Concept: Wildfire smoke compromises the human respiratory system by simultaneously paralyzing the cilia responsible for clearing mucus and degrading the protein junctions that maintain the airway epithelial barrier.
Key Distinction/Mechanism: Concentrated particulate matter from wildfire smoke explicitly triggers the MEK/ERK cellular signaling pathway, which scrambles the protein phosphorylation process controlling cytoskeletal structure. Inhibiting this specific pathway prior to exposure prevents the structural breakdown and preserves ciliary function.
Origin/History: The foundational research detailing this mechanism was conducted following the January 2025 Palisades and Eaton wildfires in Los Angeles, where UCLA researchers observed direct cellular damage in sinus tissue from affected patients and subsequently modeled the exposure using lab-grown human airway tissue.
Major Frameworks/Components:
- Airway Epithelial Barrier: The cellular structure that acts as a physical wall, preventing inhaled pathogens and fine particulates from entering the bloodstream.
- Mucociliary Clearance: The coordinated beating of hair-like cilia that sweeps mucus and trapped debris up and out of the respiratory tract.
- Protein Phosphorylation: The addition of chemical tags to proteins, which wildfire smoke alters to disrupt cellular scaffolding.
- MEK/ERK Signaling Pathway: A kinase cascade typically regulating cell growth, which, when hyperactivated by smoke exposure, dismantles ciliary architecture.
Branches of Science: Cellular Biology, Molecular Genetics, Environmental Toxicology, Pulmonology, Immunology.
Future Application: This research supports the development of a preventative MEK/ERK inhibitor formulated as an over-the-counter inhaler or nasal spray to protect high-risk populations, such as firefighters and individuals with chronic respiratory disease, prior to smoke exposure.
Why It Matters: As climate change extends wildfire seasons and expands their geographic reach, understanding this cellular damage is critical for preventing smoke-induced systemic inflammation, lung disease, heart disease, stroke, and cancer.
Live recordings show the movement of tiny hair-like structures called cilia on the surface of human airway cells. In the healthy control (left), cilia beat rapidly and in a coordinated pattern to help clear harmful particles from the lungs. After exposure to wildfire smoke (middle), cilia movement is severely impaired. When cells are treated with a drug that blocks the MEK signaling pathway (right), cilia movement is preserved, demonstrating a potential way to protect the lungs from smoke-related damage.
When the Palisades and Eaton wildfires tore through Los Angeles in January 2025, smoke blanketed the region, and air quality plunged into the hazardous range. The event highlighted an escalating environmental issue: After years of improvement, wildfire smoke is pulling air quality back in the wrong direction, and fire season, once confined to hot, dry summers, now stretches across the year.
Fine smoke particles have been linked to lung disease, stroke, heart disease, and cancer. However, the specific mechanisms by which these particles injure airway epithelial cells have remained poorly understood.
Normally, the airway has two lines of defense. Sticky mucus traps inhaled viruses, dust, and pollution, and tiny hair-like structures called cilia sweep that mucus up and out. Those cilia grow from cells in the airway lining, which form tight intercellular junctions, functioning similarly to cement between bricks, to maintain the epithelial barrier that keeps whatever the mucus doesn’t catch from reaching the rest of the body.
Now, UCLA researchers have shown that wildfire smoke attacks both defenses at once, paralyzing the cilia and loosening the tight junctions between cells. They also identified a cell signal that contributes to the damage and found that blocking it protected human airway tissue in the lab. The findings were published in Environmental Health Perspectives.
“People talk about the lung as a gateway,” said co-senior author Dr. Brigitte Gomperts, a professor of pediatrics and pulmonary medicine at the David Geffen School of Medicine at UCLA and the associate director of translational research at the UCLA Broad Stem Cell Research Center. “If the particles are small enough, and if they can break down the airway barrier, they can get into your brain and your heart, where they can cause inflammation.”
Evidence From the 2025 Los Angeles Wildfires
To see what the smoke did to human airways, the team started with nasal and sinus tissue—part of the upper airway—from 14 Los Angeles residents who had sinus surgery either before the fires, during them, or in the two weeks of smoldering afterward. Each patient was sampled at only one of those points.
Before the fires, the patients’ airway lining was intact. During the fires, it was patchy and sloughing off, with some areas missing entirely, and the protein seals between cells had fragmented. In the two weeks of smoldering that followed, the lining had partly recovered, though it remained thinner than before the fires, and its seals were only partly restored.
Under an electron microscope, tissue collected during the fires also showed dense, particle-like structures inside cells and in the spaces between them. The team identified these structures by their appearance but did not trace them to the smoke.
Everyone in the group had chronic sinus disease, and no one’s individual smoke exposure could be measured, so the samples alone can’t prove that smoke caused the damage. To test that directly, the team turned to lab-grown human airway tissue.
Mini Human Airways: Cilia Stall, Barrier Breaks
First, the researchers needed a way to expose that tissue to smoke.
“I came into the lab ready to study wildfire smoke, but without a real system to do so,” said first author Dr. Caroline Cherry, a postdoctoral scholar in the Gomperts lab.
So she improvised, adapting an exposure chamber a labmate had built for cigarette smoke. She ground pine bark from a tree on the UCLA campus, rolled it into tiny “wooden cigarettes,” and used a programmable pump to draw the smoke over the tissue. UCLA atmospheric and environmental health scientists found that the smoke’s particle sizes and chemistry were consistent with those of wood smoke measured in the environment.
The tissue itself was grown from airway stem cells isolated from donated lungs with no lung disease. Because these stem cells can renew themselves and mature into the airway’s many cell types, the resulting mini airways contained beating cilia and the protein seals between cells, much like the real thing. The team exposed the mini airways to smoke for three minutes a day for five days.
The damage accumulated with each exposure, even though the tissue got clean air in between. In unexposed tissue, about 71% of the surface showed coordinated ciliary movement. After five days of smoke, that fell to about 25%, even though the cells themselves weren’t dying off. The airway’s second defense suffered as well, as the seals between cells loosened and the barrier weakened.
Recovery was only partial. Five days after the final exposure, ciliary movement had climbed back only to about 46%, and the barrier was still weakened. While the cilia are still impaired, the airway can’t clear particles as well.
“It’s concerning in terms of general public health, because that’s quite some time for the particles to be sitting in our lungs,” Cherry said.
Blocking the Signal Behind the Damage
To find out what was contributing to the damage, the team worked with the lab of Dr. Mehdi Bouhaddou, an assistant professor of microbiology, immunology, and molecular genetics at the Geffen School of Medicine, to look at protein phosphorylation, the process cells use to switch proteins on and off by adding tiny chemical tags. Smoke scrambled these tags, especially on proteins that build cilia and hold the cell’s internal scaffolding in place.
Different signaling pathways tag different proteins, so the pattern smoke left behind pointed back to the pathways responsible. One stood out among those that control cilia and the cell’s internal scaffolding: MEK/ERK, which also helps regulate cell growth and is already the target of several cancer drugs. Follow-up tests confirmed the pathway was switched on in smoke-exposed tissue.
So the team tried blocking it, treating the tissue with an MEK inhibitor called pimasertib 30 minutes before each smoke exposure. In this set of experiments, about 48% of the surface showed coordinated ciliary movement in tissue that got no smoke. In tissue exposed to smoke without the drug, that fell to about 14%. At the highest dose of pimasertib, it maintained about 41% ciliary movement. Microscopy showed that the drug kept the cilia’s internal structure intact and helped preserve the seals between cells.
Developing a Shield for the Airways
Because the drugs were given before each exposure, these experiments tested prevention rather than repair. The team imagines a product that works the same way: an inhaler or nasal spray taken ahead of a smoky day, delivering protection straight to the airway.
“This would be for firefighters and the military population who are exposed to burn pits,” Cherry said. “But we also see this for those more at risk of having severe consequences from smoke exposure, like kids and people with lung disease or heart disease.”
This is early-stage work. Next steps include formulating the compound for inhalation and conducting safety studies.
“Our goal is to develop a product that’s affordable and available over the counter,” Gomperts said. “We want anyone around the world to be able to get it.”
The compositions and methods described in this study are covered by a patent application filed by the UCLA Technology Development Group on behalf of the Regents of the University of California, with Gomperts and Cherry listed as inventors.
Funding: This research was supported by the University of California Office of the President’s California Firefighter Cancer Prevention and Research Program, the National Institutes of Health, the UCLA Environmental and Molecular Toxicology Program, the Tobacco-Related Disease Research Program, the Burroughs Wellcome Fund, the UCLA Health Jonsson Comprehensive Cancer Center, the Howard Hughes Medical Institute, the UCLA Molecular Biology Institute, the UCLA Cellular and Molecular Biology Training Program, the UCLA Health Jonsson Comprehensive Cancer Center and UCLA Broad Stem Cell Research Center Ablon Scholars Program, the UCLA AIDS Institute, the James B. Pendleton Charitable Trust, and the McCarthy Family Foundation.
Published in journal: Environmental Health Perspectives
Authors: Caroline Cherry, Declan M. Winters, Abdo Durra, Chandani Sen, Andrew Frauenpreis, Emily Hou, Coline Luo, Tammy M. Rickabaugh, Luca Lit, Sarah Siegel, Matthew Aaron Blumberg, Kristen Castillo, Andrew J. Lund, Catherine Banach, Zhuoying Lin, Saagar Patel, Mikayla R. Murphree, Sara Makanani, Prashant Kaushal, Immy Ashley, Jeffrey D. Suh, Nicholas J. Jackson, David Gonzalez, Yifang Zhu, Suzanne E. Paulson, Chen Yuan Kam, Daniel Beswick, Eszter K. Vladar, Amarbir S. Gill, Mehdi Bouhaddou, and Brigitte N. Gomperts
Source/Credit: University of California / Health | Linda Wang
Edited by: Scientific Frontline
Reference Number: cbio111626_01